Sigyn Therapeutics, Inc. (SIGY) › Operating IncomeSigyn Therapeutics, Inc. (SIGY) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$387.5K2015: -$2.25M2017: -$2.03M2018: -$1.00M2019: -$518.0K2020: -$916.4K2021: -$2.01M2022: -$2.15M2023: -$2.46M2024: -$2.52M-$2.52M2014Operating Income (USD)2024Fiscal YearOperating IncomeChange YoY2024-$2.52M-2.6%2023-$2.46M-14.3%2022-$2.15M-6.9%2021-$2.01M-119.1%2020-$916.4K-76.9%2019-$518.0K+48.4%2018-$1.00M+50.5%2017-$2.03M—2015-$2.25M-481.4%2014-$387.5K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share